- Home
- AMOD vs CLGN Comparison
AMOD vs CLGN Comparison
Compare AMOD & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMOD
- CLGN
- Stock Information
- Founded
- AMOD 2014
- CLGN 2004
- Country
- AMOD United States
- CLGN Israel
- Employees
- AMOD N/A
- CLGN N/A
- Industry
- AMOD
- CLGN Industrial Specialties
- Sector
- AMOD
- CLGN Health Care
- Exchange
- AMOD NYSE
- CLGN Nasdaq
- Market Cap
- AMOD 42.7M
- CLGN 48.1M
- IPO Year
- AMOD N/A
- CLGN N/A
- Fundamental
- Price
- AMOD $1.89
- CLGN $4.00
- Analyst Decision
- AMOD
- CLGN Strong Buy
- Analyst Count
- AMOD 0
- CLGN 2
- Target Price
- AMOD N/A
- CLGN $12.50
- AVG Volume (30 Days)
- AMOD 110.6K
- CLGN 14.1K
- Earning Date
- AMOD 01-01-0001
- CLGN 11-27-2024
- Dividend Yield
- AMOD N/A
- CLGN N/A
- EPS Growth
- AMOD N/A
- CLGN N/A
- EPS
- AMOD N/A
- CLGN N/A
- Revenue
- AMOD N/A
- CLGN $650,000.00
- Revenue This Year
- AMOD N/A
- CLGN N/A
- Revenue Next Year
- AMOD N/A
- CLGN $692.59
- P/E Ratio
- AMOD N/A
- CLGN N/A
- Revenue Growth
- AMOD N/A
- CLGN N/A
- 52 Week Low
- AMOD $1.70
- CLGN $3.24
- 52 Week High
- AMOD $13.49
- CLGN $6.75
- Technical
- Relative Strength Index (RSI)
- AMOD N/A
- CLGN 46.53
- Support Level
- AMOD N/A
- CLGN $3.39
- Resistance Level
- AMOD N/A
- CLGN $4.51
- Average True Range (ATR)
- AMOD 0.00
- CLGN 0.20
- MACD
- AMOD 0.00
- CLGN 0.02
- Stochastic Oscillator
- AMOD 0.00
- CLGN 45.04
About AMOD ALPHA MODUS HOLDINGS INC
Alpha Modus Holdings Inc is a technology company with a core focus on artificial intelligence in retail. It is engaged in creating, developing and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.